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Abstract
The nitrone spin trap 5,5-dimethyl-1-pyrroline N-oxide (DMPO) is commonly used to study free
radicals. Due to its free radical trapping properties, DMPO is thought to reduce free radial-
mediated oxidative damage and other related cellular responses. The purpose of this study was to
assess the effect of DMPO on lipopolysaccharide (LPS)-induced inflammation, endoplasmic
reticulum (ER)-stress, and apoptosis in RAW 264.7 cells. The results showed that DMPO at 50
mM inhibited inducible nitric oxide synthase expression when added shortly after LPS treatment
(≤3 h). Interestingly, DMPO increased anti-inflammatory heme oxygenase-1 (HO-1) expression
and reversed LPS-induced decrease in HO-1 expression. LPS could increase cellular ER stress as
indicated by CHOP induction; DMPO reduced LPS effect on CHOP expression. Unexpectedly,
DMPO had a synergistic effect with LPS on increased caspase-3 activity. Overall, DMPO harbors
multiple modulating effects, but may induce apoptosis in LPS-stressed cells when given at 50
mM, an effective dose for its anti-inflammatory activity in vitro. Our data provide clues for further
understanding of DMPO, the old nitrone spin trap with therapeutic potential.
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INTRODUCTION
Reactive chemical species including free radicals and non-free radical species have a
significant role in cell signaling and tissue damage [1]. Nitrone spin traps are a group of
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synthetic chemicals initially designed for stabilizing free radicals to allow their detection by
electron spin resonance (ESR) spectroscopy [2]. The nitrone spin trap 5,5-dimethyl-1-
pyrroline N-oxide (DMPO) was first introduced by Janzen and his colleagues about 40 years
ago [3]. Since then, DMPO has been widely used in the ESR spin trapping technique and is
becoming the most popular nitrone spin trap in free radical research [4, 5]. DMPO received
extra attention during the last 10 years due to the development of an anti-DMPO antibody,
which has largely expanded the application of DMPO in the study of free radicals in
biological systems ([6] and references cited therein). Today, traditional immunoassays (e.g.,
immunofluorenscence and Western blot) in combination with anti-DMPO antibody can be
used as an alternative and convenient methodology to detect free radicals in vitro and also in
vivo [6–9].
Free radicals are highly reactive and therefore very short half-lived. In order to overcome the
radical decay mechanism, high concentrations (e.g., 200–500 mM) of DMPO are added
immediately before or during the formation of free radicals to trap them and allow the
accumulation of DMPO-radical adducts [6]. Free radicals and other reactive oxygen species
(ROS) are ubiquitous in the living cells and are involved in various cellular processes.
Consequently, it is likely that high concentrations of DMPO used to trap free radicals in cell
systems can alter cell physiology and cell response to stress. On the other hand,
overproduction of free radicals and other ROS is known to cause oxidative stress, which is
associated with inflammation, endoplasmic reticulum (ER) stress, and apoptosis that affect
cell homeostasis and fate [10]. Therefore, by trapping free radicals and blocking free radical
chain reactions, DMPO, at appropriate doses, may reduce free radical-mediated oxidative
stress and cell damage [11]. In this regard, nitrone spin straps have been actively studied for
their potential therapeutic values as anti-oxidant and anti-inflammatory agents. Notable
examples of this kind of spin traps include the phenyl-N-tert-butylnitrone (PBN) and its
derivatives, which produced several protective effects in animal models of disease and
injury, including endotoxic shock and intracerebral glioma [12, 13]. Besides, PBN was
shown to significantly slow down the aging process in animals by reducing age-associated
oxidative damage [14].
The evidence for the pharmacological activities of DMPO is relatively limited. It has been
reported that DMPO reduces the mortality resulting from endotoxic shock in a rat model of
sepsis [15], and protects against reperfusion-induced injury or arrhythmias in isolated rat
heart models [16, 17]. We recently demonstrated that DMPO inhibited lipopolysaccharide
(LPS)-induced ROS production and inflammatory responses, and thereby protected cells
from LPS-induced cell damage in a macrophage cell line [18, 19]. However, the effects of
DMPO on other LPS-related cellular responses such as ER stress and apoptosis are
unknown. Therefore, the main purpose of this study was to investigate the effects of DMPO
on LPS-induced cellular stress responses, such as ER stress and apoptosis.
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RAW 264.7 cells were obtained from American Type Culture Collection (TIB-71,
Rockville, MD) and grown in DMEM supplemented with 10% fetal bovine serum at 37°C in
a 5% CO2 incubator. Cells less than 25 passages were used in this study.
LPS and DMPO Treatments
LPS (Escherichia coli serotype 055:B5, L2637) was from Sigma (St. Louis, MO). DMPO
was from Alexis Biochemicals (San Diego, CA). DMPO stock aliquots (10 M) were stored
under an argon atmosphere at −80°C until use. Cells were allowed to attach to the culture
ware for at least 2 h before exposure to DMPO and/or LPS.
Nitric Oxide Assay
RAW 264.7 cells (1.6×106 per well) were treated with 1 ng/ml LPS and/or 50 mM DMPO
for 24 h. Culture medium was collected for the determination of both nitrite and nitrate as
indicators of nitric oxide (·NO) production using a commercial Nitric Oxide Colorimetric
Assay kit from BioVision (Mountain View, CA). In a second set of experiments, RAW
264.7 cells were pretreated with 50 mM DMPO for 4 h, then washed with phosphate
buffered saline (PBS) to remove extracellular DMPO, and LPS (1 ng/ml) was added and
cells continued incubation for another 20 h. Nitrite accumulation in the culture medium was
determined using the classical Griess reaction.
Western Blot Analysis
Following treatments with LPS and/or DMPO for the indicated times, RAW 264.7 cells
were rinsed with PBS, cell lysates were prepared, and Western blot analysis was performed
as described previously [18]. The following primary antibodies were used: pro-caspase-3,
cleaved caspase-3 (Asp175), protein kinase-like endoplasmic reticulum kinase (PERK),
inositol-requiring enzyme 1-alpha (IRE1α), binding immunoglobulin protein (BiP), protein
disulfide isomerase (PDI) (Cell Signaling Technology, Danvers, MA), heme oxygenase-1
(HO-1), 14-3-3 (Epitomics, Burlingame, CA), iNOS, β-actin, α-tubulin (Sigma), Bcl-2
(Abcam, Cambridge, MA), and GADD13 (CHOP) (Santa Cruz Biotechnology, Santa Cruz,
CA). All primary antibodies were diluted at 1:1000 except for anti-CHOP at 1:500.
Confocal Imaging
Following LPS and/or DMPO treatment, cells were washed and stained with ER-Tracker
Red dye (Molecular Probes, Eugene, OR) in HBSS for 20 min at 37°C. Stained cells were
fixed in 4% paraformaldehyde and then serially incubated with rabbit anti-DMPO antibody
(Alexis Biochemicals) and goat anti-rabbit Alexa Fluor 488 (Invitrogen, Carlsbad, CA).
Finally, cells were rinsed and mounted on cover glasses with Prolong Gold antifade reagent
with 4′-6-diamidino-2-phenylindole (DAPI, Invitrogen), and the immunostaining examined
by confocal imaging using a Leica SP2 MP Confocal Microscopy.
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After treated with LPS and/or DMPO for 24 h, RAW 264.7 cells were lysed for 20 min in
the chilled cell lysis buffer provided with the Caspase-3/CPP32 Colorimetric Assay kit
(BioVision). Following spinning at 12,000 g for 10 min at 4°C, the cytosolic fraction was
tested for caspase-3 activity using the commercial assay kit.
Annexin V Staining
Following treatments with LPS and/or DMPO overnight, RAW 264.7 cells were incubated
in accutase-enzyme cell detachment medium (eBioscience, San Diego, CA) for 10 min.
Then, cells were serially stained with fluorochrome-conjugated Annexin V and propidium
iodide (PI) according to the Annexin V Apoptosis Detection kit’s instruction (eBioscience).
Apoptotic cells were analyzed on the BD FACSAria flow cytometer (BD Biosciences, San
Jose, CA) within 1 h.
Protein Assay
The protein concentrations in cell lysates were determined using a BCA protein assay kit
(Pierce Labs, Rockford, IL) with bovine serum albumin as standard.
Statistical Analysis
Results are expressed as mean values of 2–4 assays ± SEM. Differences between the
treatment groups were tested by two-way analysis of variance (group×experiment) using the
Statistix software (Analytical software, Tallahassee, FL). A difference between the groups
with a P<0.05 was considered as significant.
RESULTS
Previous studies have shown that DMPO at 50 mM had no remarkable cytotoxicity, and
provided maximal protection from LPS-induced cell damage [19]. Based on those data, in
the present study we used a similar condition to assess the effect of DMPO on LPS-induced
cellular stress response in RAW 264.7 cells.
DMPO Reduces LPS-induced ·NO Production and iNOS Expression
LPS activates RAW 264.7 macrophages to produce ROS and inflammatory mediators
including ·NO [20, 21]. ·NO is rapidly oxidized to nitrite and nitrate, which were measured
in the culture medium following treatment of RAW 264.7 cells with 1 ng/ml LPS and/or 50
mM DMPO for 24 h. In agreement with a previous report [22], we found that LPS induced
nitrite and nitrate accumulation in culture medium at a ratio of approximately 3:2. DMPO
reduced the production of nitrite and nitrate, but did not affect the nitrite/nitrate ratio (Fig.
1A). To further test the effect of DMPO on LPS-induced ·NO production, RAW 264.7 cells
were pre-incubated with DMPO for 4 h and then rinsed to remove DMPO. LPS was
subsequently added to stimulate cells for another 20 h. The results showed that DMPO pre-
incubation significantly reduced LPS-induced ·NO production (Fig. 1B). To test the most
effective time point for addition of DMPO in the regulation of iNOS expression, RAW
264.7 cells were treated with 1 ng/ml LPS for 24 h. In these experiments, DMPO was either
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added simultaneously with LPS or up to 24 h after addition of LPS. Western blot analysis of
iNOS showed that DMPO caused a strong inhibition of iNOS expression when it was added
within 3 h after LPS was added. DMPO showed little effect when added 6 h after LPS
stimulation (Fig. 1C), suggesting that DMPO inhibits LPS-induced iNOS gene induction.
DMPO Regulates HO-1 Expression
The iNOS expression is controlled mainly by the redox-sensitive transcriptional factor NF-
κB, however, it can also be regulated by other mechanisms as well, including c-Jun N-
terminal kinase (JNK) and HO-1 [23, 24]. JNK is rapidly phosphorylated following LPS
stimulation. We demonstrated that DMPO at 25 mM inhibited LPS-induced JNK
phosphorylation with a similar effectiveness as SP600125 (20 μM, Sigma), a
pharmacological inhibitor of JNK (data not shown). HO-1 is an inducible anti-inflammatory
molecule by LPS in mouse peritoneal macrophages and RAW 264.7 cells [24, 25]. HO-1 is
an important feedback negative regulatory mechanism following LPS treatment. To
determine the effect of DMPO on HO-1 expression, RAW 264.7 cells were treated with LPS
and/or DMPO for 24 h. We found that treatment of the cells with LPS for 24 h caused low
expression of HO-1. Interestingly, DMPO blocked the LPS effect on HO-1 expression, and
profoundly increased HO-1 expression when it was added alone (Fig, 1D), consistent with
the anti-inflammatory property of DMPO. To investigate the causes for the decreased
expression of HO-1 by LPS, we treated RAW 264.7 cells with LPS for different time points,
and HO-1 protein expression was analyzed by Western blot. The results showed that HO-1
expression was variable, with a decrease at 3–9 h, an increase at 12–18 h, and again a
decrease at 24 h (Fig. 1E), confirming the observation in Fig. 1D.
DMPO Affects LPS-induced ER Stress
LPS is known to induce ER stress in macrophages as exemplified by the induction of the
transcription factor CHOP [26]. Our previous study suggested that ER might be an
important cellular compartment for the generation of protein-centered radicals following
LPS treatment [19]. Therefore, we determined the co-location of ER and protein-centered
radicals using ER-Tracker dye and immunostaining with anti-DMPO antibody (Fig 2A). The
appearance of nitrone adducts inside cells treated with LPS and DMPO indicates increased
oxidative damage and possible ER stress following LPS treatment. To determine the effect
of DMPO on LPS-induced ER stress, RAW 264.7 cells were treated with LPS and/or
DMPO for 24 h, and several ER stress-associated proteins including PERK, BiP, IRE1α,
PDI and CHOP were measured by Western blot (Fig. 2B). Our results showed that treatment
with DMPO reduced the baseline expression levels of CHOP and IRE1α. LPS decreased
PERK expression, but, as expected, it induced CHOP synthesis. DMPO partially prevented
LPS-induced decrease in PERK expression and significantly inhibited LPS induced CHOP
synthesis (Fig. 2C). Interestingly, although DMPO caused a slight decrease in the basal
expression of IRE1α, it enhanced LPS-induced IRE1α expression. The chaperone PDI and
BiP were not affected by any of the treatments with respect to the no treatment control.
DMPO Inhibits LPS Effect on 14-3-3 and Bcl-2 Expression
It has been suggested that LPS-induced oxidative stress, inflammation, and ER stress may
lead to apoptosis, a process characterized by an imbalance of the expression of pro- and anti-
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apoptotic proteins [27]. Therefore, we examined two anti-apoptotic proteins, 14-3-3-and
Bcl-2, in LPS-treated cells. As shown in Fig. 3A, LPS decreased the expression of both anti-
apoptotic proteins, however, the expression levels of these two proteins was restored to the
control levels when DMPO was present in the culture medium.
DMPO Increases LPS Effect on Capase-3 Activity and Apoptosis
Caspase-3 is an important executer of the apoptotic program [28]. Therefore, we examined
the cleavage of pro-caspase-3 and the formation of active caspase-3 in cells treated with LPS
and/or DMPO for 24 h. As shown in Fig. 3B, LPS increased the cleaved caspase-3 with a
consequent diminution of pro-caspase-3. Curiously, DMPO enhanced LPS effect on
caspase-3 activation. To confirm this observation, we further determined the caspase-3
enzyme activity. As expected, our data were consistent with a synergistic effect of DMPO
on LPS-induced caspase-3 activation (Fig. 3C). Finally, cell death was analyzed by using the
Annexin V and PI staining. Generally, the number of the Annexin V positive/PI negative
cells and that of the Annexin V positive/PI positive cells showed a similar increasing trend
following DMPO and LPS exposure. However, since the number of the Annexin V
positive/PI negative cells was less than one tenth of that of the Annexin V positive/PI
positive cells in all treatment groups, apoptosis was no longer separated and only the data of
Annexin V positive cells are shown (Fig. 3D). It was found that both LPS and DMPO
induced cells to undergo the apoptotic program. However, their combined effect did not
reach significance.
DISCUSSION
LPS priming of macrophages activates the redox-sensitive NF-κB [21, 29], leading to the
transcription of various genes encoding inflammatory mediators and enzymes (e.g., TNF-α
and iNOS). These mediators and enzymes may amplify inflammatory signaling and cause
cell damage via autocrine and paracrine routes. Western blot analysis of iNOS expression in
cells to which DMPO was added at different time points after LPS stimulation supports the
notion that DMPO disturbs LPS-initiated early signaling, which is the basis for its anti-
inflammatory activities including the decreased TNF-α and ·NO production.
HO-1 is the key enzyme in the degradation of heme into biliverdin, iron, and carbon
monoxide (CO). HO-1 and its byproducts are known to participate in the negative feedback
regulation of inflammatory responses [30, 31]. Increasing evidence support that HO-1
induction is closely related to the negative control of iNOS expression and ·NO production
in LPS-activated macrophages [24, 25, 32]. The inhibition of iNOS by HO-1 is thought to
go through several regulatory mechanisms including degrading heme needed for iNOS
synthesis and CO-binding to iNOS leading to the blockage of ·NO production [25]. The
upregulation of HO-1 function has been found to be a common action mechanism of many
anti-inflammatory agents and natural products [32, 33]. In this regard, DMPO anti-
inflammatory effects may operate by increasing the baseline HO-1 expression in RAW
264.7 cells and inhibiting LPS-mediated decrease in HO-1 expression. The decreased HO-1
expression in RAW 264.7 cells exposed to LPS for 24 h was unexpected because LPS was
seen to induce HO-1 in both primary macrophages and RAW 264.7 cells [24, 25, 32]. These
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observations are in apparent discrepancy with our data. Consequently, we determined the
HO-1 expression in RAW 264.7 cells treated with LPS for different time points, and found
that HO-1 expression was highly variable in a time-dependent pattern (Fig. 3B). This
observation is in agreement with previous reports [24, 25] and may explain the apparent
discrepancy as we mentioned before. For instance, Srisook et al. [25] reported that LPS
induced HO-1 protein expression in a biphasic manner, a small peak at 1–2 h and a marked
peak between 10–24 h following LPS treatment. These authors suggested that superoxide
radical anion produced shortly upon LPS stimulation is responsible for the first phase HO-1
expression and ·NO whose production starts at 6 h is responsible for the significant second-
phase HO-1 expression [25]. Therefore, HO-1 induction reflects altered oxidative status and
cell response to oxidative damage [34].
ER is the site for folding and refolding of newly synthesized proteins to be secreted. Any
condition that interferes with the normal ER functions may lead to accumulation of toxic
protein aggregates that cause ER stress. For example, activation of macrophages with LPS
causes ER stress [35]. To deal with the ER stress, the cells activate the unfolded protein
response pathway mediated through ER-transmembrane protein factors including PERK and
IRE1α [10]. BiP, an ER chaperone, negatively regulates PERK and IRE1α by binding and
stabilizing them in their inactive state. In ER stress, PDI is induced to assist protein post-
translational folding events. Activation and/or upregulation of these ER stress molecules
lead to the expression of pro-apoptotic proteins (e.g., CHOP) that trigger inflammation and
apoptosis [26, 36]. We found that DMPO and LPS had different effects on these ER stress
markers. DMPO alone decreased IRE1α and CHOP expression, suggesting that DMPO may
modulate baseline ER stress markers (Fig. 2B). On the other hand, we found that LPS
significantly reduced PERK expression, but this effect was inhibited by DMPO. Although
DMPO enhanced LPS-induced IRE1α expression, it decreased CHOP expression, indicating
that DMPO at 50 mM consistently protected cells from LPS-induced ER stress. It should be
noted that to gain more understanding of the modulating effects of DMPO on the ER stress,
it would be necessary to further determine the phosphorylation levels of ER stress markers
and other pathways that contribute to CHOP induction.
LPS-initiated inflammatory signaling and CHOP induction modulate Bcl-2 expression and
induce apoptosis [37, 38]. In the apoptosis cascades, caspase-3 is an executioner of
apoptosis. Proteolytic cleavage of procaspase-3 leads to caspase-3 activation, which cleaves
over hundred different cellular proteins that ultimately result in apoptotic cell death [28]. We
found that DMPO reversed LPS-induced decrease in the expression of 14-3-3 and Bcl-2,
suggesting an anti-apoptotic effect of DMPO. However, DMPO increased caspase-3
activation and the number of the Annexin V-positive cells, and had a synergistic effect with
LPS-induced caspase-3 activity. These evidences suggest that DMPO, under the conditions
used in our experiments, was somewhat pro-apoptotic. Since DMPO was simultaneously
added with LPS, our apoptosis data more likely reflect an early effect of DMPO on the
secretion and further autocrine/paracrine pro-apoptotic effect of TNF-α, rather than the late
NO pro-apoptotic effect, which would require iNOS expression. Notably, the protective
effects of DMPO against LPS-induced cell death have been assessed by different methods
such as MTT reduction, Trypan blue exclusion, and lactate dehydrogenase release [18, 19].
It is interesting in the future to clarify why DMPO protected cells from LPS-induced death
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while it synergistically induced caspase-3 activation. It is possible that DMPO activates
some potent survival signaling pathways in the meantime that outcompete the apoptosis
mechanisms.
Taken together, our data indicate that the nitrone spin trap DMPO modulates a wide range of
LPS-induced cellular responses, putatively through trapping free radicals and interfering
with ROS production. DMPO has been suggested to be robustly anti-inflammatory, but it
may be pro-apoptotic, especially when used at high doses.
Acknowledgments
The project was supported by Award Number 5R00ES015415-04 to DCR from the National Institute of
Environmental Health Sciences. The content is solely the responsibility of the authors and does not necessarily
represent the official views of the National Institute of Environmental Health Sciences or the National Institutes of
Health. DCR is an Affiliated Researcher of the Laboratory of Pharmacology and Toxicology at the NIEHS,
USNIH, DHHS.
References
1. Winterbourn CC. Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol.
2008; 4:278–86. [PubMed: 18421291]
2. Janzen EG. Spin trapping. Methods Enzymol. 1984; 105:188–98. [PubMed: 6328178]
3. Janzen EG, Liu JI. Radical addition reactions of 5,5-dimethyl-l-pyrroline-l-oxide. ESR spin trapping
with a cyclic nitrone. J Magn Reson. 1973; 9:510–513.
4. Janzen EG, Poyer JL, Schaefer CF, Downs PE, DuBose CM. Biological spin trapping. II. Toxicity
of nitrone spin traps: dose-ranging in the rat. J Biochem Biophys Methods. 1995; 30:239–47.
[PubMed: 8621883]
5. Ranguelova K, Mason RP. The fidelity of spin trapping with DMPO in biological systems. Magn
Reson Chem. 2011; 49:152–8. [PubMed: 21246623]
6. Gomez-Mejiba SE, Zhai Z, Akram H, Deterding LJ, Hensley K, Smith N, et al. Immuno-spin
trapping of protein and DNA radicals: “tagging” free radicals to locate and understand the redox
process. Free Radic Biol Med. 2009; 46:853–65. [PubMed: 19159679]
7. Mason RP. Using anti-5,5-dimethyl-1-pyrroline N-oxide (anti-DMPO) to detect protein radicals in
time and space with immuno-spin trapping. Free Radic Biol Med. 2004; 36:1214–23. [PubMed:
15110386]
8. Ramirez DC, Mejiba SE, Mason RP. Immuno-spin trapping of DNA radicals. Nat Methods. 2006;
3:123–7. [PubMed: 16432522]
9. Gomez-Mejiba SE, Zhai Z, Gimenez MS, Ashby MT, Chilakapati J, Kitchin K, et al.
Myeloperoxidase-induced genomic DNA-centered radicals. J Biol Chem. 2010; 285:20062–71.
[PubMed: 20406811]
10. Zhang K. Integration of ER stress, oxidative stress and the inflammatory response in health and
disease. Int J Clin Exp Med. 2010; 3:33–40. [PubMed: 20369038]
11. Ramirez DC, Mejiba SE, Mason RP. Copper-catalyzed protein oxidation and its modulation by
carbon dioxide: enhancement of protein radicals in cells. J Biol Chem. 2005; 280:27402–11.
[PubMed: 15905164]
12. Floyd RA, Kopke RD, Choi CH, Foster SB, Doblas S, Towner RA. Nitrones as therapeutics. Free
Radic Biol Med. 2008; 45:1361–74. [PubMed: 18793715]
13. Kotake Y. Pharmacologic properties of phenyl N-tert-butylnitrone. Antioxid Redox Signal. 1999;
1:481–99. [PubMed: 11233146]
14. Floyd RA, Hensley K, Forster MJ, Kelleher-Anderson JA, Wood PL. Nitrones as neuroprotectants
and antiaging drugs. Ann N Y Acad Sci. 2002; 959:321–9. [PubMed: 11976206]
15. Hamburger SA, McCay PB. Endotoxin-induced mortality in rats is reduced by nitrones. Circ
Shock. 1989; 29:329–34. [PubMed: 2688966]
Zhai et al. Page 8






















16. Tosaki A, Haseloff RF, Hellegouarch A, Schoenheit K, Martin VV, Das DK, et al. Does the
antiarrhythmic effect of DMPO originate from its oxygen radical trapping property or the structure
of the molecule itself? Basic Res Cardiol. 1992; 87:536–47. [PubMed: 1336665]
17. Zuo L, Chen YR, Reyes LA, Lee HL, Chen CL, Villamena FA, et al. The radical trap 5,5-
dimethyl-1-pyrroline N-oxide exerts dose-dependent protection against myocardial ischemia-
reperfusion injury through preservation of mitochondrial electron transport. J Pharmacol Exp Ther.
2009; 329:515–23. [PubMed: 19201989]
18. Zhai Z, Gomez-Mejiba SE, Zhu H, Lupu F, Ramirez DC. The spin trap 5,5-dimethyl-1-pyrroline
N-oxide inhibits lipopolysaccharide-induced inflammatory response in RAW 264. 7 cells. Life Sci.
2012; 90:432–9. [PubMed: 22285597]
19. Zhai Z, Gomez-Mejiba SE, Gimenez MS, Deterding LJ, Tomer KB, Mason RP, et al. Free radical-
operated proteotoxic stress in macrophages primed with lipopolysaccharide. Free Radic Biol Med.
2012; 53:172–81. [PubMed: 22580125]
20. Nathan CF. Secretory products of macrophages. J Clin Invest. 1987; 79:319–26. [PubMed:
3543052]
21. Muller JM, Ziegler-Heitbrock HW, Baeuerle PA. Nuclear factor kappa B, a mediator of
lipopolysaccharide effects. Immunobiology. 1993; 187:233–56. [PubMed: 8330898]
22. Stuehr DJ, Marletta MA. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer
Res. 1987; 47:5590–4. [PubMed: 3117354]
23. Lahti A, Jalonen U, Kankaanranta H, Moilanen E. c-Jun NH2-terminal kinase inhibitor anthra(1,9-
cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA
in activated macrophages. Mol Pharmacol. 2003; 64:308–15. [PubMed: 12869635]
24. Ashino T, Yamanaka R, Yamamoto M, Shimokawa H, Sekikawa K, Iwakura Y, et al. Negative
feedback regulation of lipopolysaccharide-induced inducible nitric oxide synthase gene expression
by heme oxygenase-1 induction in macrophages. Mol Immunol. 2008; 45:2106–15. [PubMed:
18022235]
25. Srisook K, Cha YN. Biphasic induction of heme oxygenase-1 expression in macrophages
stimulated with lipopolysaccharide. Biochem Pharmacol. 2004; 68:1709–20. [PubMed: 15450936]
26. Endo M, Mori M, Akira S, Gotoh T. C/EBP homologous protein (CHOP) is crucial for the
induction of caspase-11 and the pathogenesis of lipopolysaccharide-induced inflammation. J
Immunol. 2006; 176:6245–53. [PubMed: 16670335]
27. Yadav UC, Kalariya NM, Srivastava SK, Ramana KV. Protective role of benfotiamine, a fat-
soluble vitamin B1 analogue, in lipopolysaccharide-induced cytotoxic signals in murine
macrophages. Free Radic Biol Med. 2010; 48:1423–34. [PubMed: 20219672]
28. Tan AC, Konczak I, Sze DM, Ramzan I. Molecular pathways for cancer chemoprevention by
dietary phytochemicals. Nutr Cancer. 2011; 63:495–505. [PubMed: 21500099]
29. Clark RA, Valente AJ. Nuclear factor kappa B activation by NADPH oxidases. Mech Ageing Dev.
2004; 125:799–810. [PubMed: 15541774]
30. Hualin C, Wenli X, Dapeng L, Xijing L, Xiuhua P, Qingfeng P. The Anti-inflammatory
Mechanism of Heme Oxygenase-1 Induced by Hemin in Primary Rat Alveolar Macrophages.
Inflammation. 2011
31. Chung HT, Choi BM, Kwon YG, Kim YM. Interactive relations between nitric oxide (NO) and
carbon monoxide (CO): heme oxygenase-1/CO pathway is a key modulator in NO-mediated
antiapoptosis and anti-inflammation. Methods Enzymol. 2008; 441:329–38. [PubMed: 18554543]
32. Lin HY, Juan SH, Shen SC, Hsu FL, Chen YC. Inhibition of lipopolysaccharide-induced nitric
oxide production by flavonoids in RAW264. 7 macrophages involves heme oxygenase-1. Biochem
Pharmacol. 2003; 66:1821–32. [PubMed: 14563492]
33. Hou CC, Huang CC, Shyur LF. Echinacea alkamides prevent lipopolysaccharide/D-galactosamine-
induced acute hepatic injury through JNK pathway-mediated HO-1 expression. J Agric Food
Chem. 2011; 59:11966–74. [PubMed: 21985290]
34. Applegate LA, Luscher P, Tyrrell RM. Induction of heme oxygenase: a general response to oxidant
stress in cultured mammalian cells. Cancer Res. 1991; 51:974–8. [PubMed: 1988141]
Zhai et al. Page 9






















35. Nakayama Y, Endo M, Tsukano H, Mori M, Oike Y, Gotoh T. Molecular mechanisms of the LPS-
induced non-apoptotic ER stress-CHOP pathway. J Biochem. 2010; 147:471–83. [PubMed:
19919955]
36. Jian B, Hsieh CH, Chen J, Choudhry M, Bland K, Chaudry I, et al. Activation of endoplasmic
reticulum stress response following trauma-hemorrhage. Biochim Biophys Acta. 2008; 1782:621–
6. [PubMed: 18801427]
37. Seminara AR, Ruvolo PP, Murad F. LPS/IFNgamma-induced RAW 264. 7 apoptosis is regulated
by both nitric oxide-dependent and -independent pathways involving JNK and the Bcl-2 family.
Cell Cycle. 2007; 6:1772–8. [PubMed: 17622798]
38. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ. Gadd153 sensitizes cells to
endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol
Cell Biol. 2001; 21:1249–59. [PubMed: 11158311]
Zhai et al. Page 10






















Fig. 1. DMPO modulates iNOS and HO-1 expression in LPS-treated RAW 164.7 cells
(A) RAW 264.7 cells were incubated in 6-well plates with LPS (1 ng/ml) and/or DMPO (50
mM) for 24 h, then culture supernatants were collected for the determination of nitrite and
nitrate by using a colorimetric assay. (B) The cells were pre-incubated with 50 mM DMPO
for 4 h in 96-well plates, then rinsed to remove DMPO and subsequently incubated with
1ng/ml LPS for another 20 h. Supernatants were collected for nitrite measurement by using
the Griess assay. (C) Western blot analysis of iNOS expression in cells incubated with 1
ng/ml LPS and/or 50 mM DMPO. DMPO was added simultaneously with LPS (0 h) or at
different times after LPS addition (0.5, 1, 3, 6 or 24 h). After incubation for total 24 h
following LPS treatment, cells were harvested and the iNOS expression was assessed in the
cell homogenates. Note that the addition of DMPO at 0, 0.5, or 1 h after LPS addition (or 24,
23.5, 23 h before harvesting the cells) resulted in no expression of iNOS, whereas DMPO
added 3 or 6 h after LPS treatment (or 21 or 18 h before harvesting the cells) resulted in the
decreased or no effect on iNOS expression. (D) RAW 264.7 cells were treated with LPS (1
ng/ml) and/or DMPO (50 mM) for 24 h, HO-1 expression was assessed by Western blot
analysis with β-actin as a loading control. (E) Western blot analysis of HO-1 expression in
cells treated with 1ng/ml LPS for different times. HO-1 expression was estimated with α-
tubulin as a loading control. Data are shown as mean values ± SEM of 2–4 experiments run
in duplicate. *P<0.05 vs baseline control; #P<0.05 vs LPS treated group.
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Fig. 2. DMPO modulates LPS-induced ER stress in RAW 264.7 cells
(A) Following treatments with LPS and/or DMPO for 24 h, living cells were stained with
ER-Tracker red dye (red) and then fixed. Fixed cells were visualized by confocal imaging of
cells immunostained for nucleus and nitrone adducts using DAPI (blue) and Alexa Fluor 488
secondary antibody conjugates (green), respectively. Scale bar: 20 μm. (B) Cells were
treated with LPS (1 ng/ml) and DMPO (50 mM) for 24 h. Equal amounts of cell lysates
were prepared and analyzed by Western blot for ER stress markers, i.e., BiP, PERK, IRE1a,
CHOP, and PDI. Protein expression of these ER stress markers was estimated using β-actin
as a loading control. (C) The CHOP expression was digitally quantitated using the ImageJ
software. Data are shown as mean values ± SEM of 4 experiments. *P<0.05 vs baseline
control; #P<0.05 vs LPS treated group.
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Fig. 3. Effect of DMPO on anti-apoptotic and apoptotic markers in LPS-treated macrophages
RAW 264.7 cells were treated with LPS (1 ng/ml) and DMPO (50 mM) for 24 h. (A) Equal
amounts of cell lysates were analyzed by Western blot for the anti-apoptotic markers 14-3-3
and Bcl-2. (B) Caspase -3 cleavage was analyzed in cell lysates by Western blotting and
estimated with β-actin as a loading control. (C) Caspase-3 activity was measured by using a
colorimetric assay. (D) Cell death was assessed by Annexin V staining and analyzed by flow
cytometry. Data are shown as mean values ± SEM of 2–3 independent experiments run in
triplicate. *P<0.05 vs baseline control; #P<0.05 vs LPS treatment control.
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